Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 9.12a
Adjusted Patient Survival, Deceased Donor Liver Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
10,369
94.6%
0.2%
10,369
89.1%
0.3%
30,505
73.7%
0.3%
50,506
59.9%
0.3%
Primary Diagnosis
Non-Cholestatic Cirrhosis
6,169
94.7%
0.3%
6,169
88.8%
0.4%
18,620
73.1%
0.4%
31,956
57.3%
0.4%
Cholestatic Liver Disease/Cirrhosis
813
95.9%
0.7%
813
92.2%
1.0%
2,530
82.7%
0.9%
4,707
71.2%
0.9%
Acute Hepatic Necrosis
582
90.6%
1.3%
582
86.8%
1.5%
1,923
72.0%
1.2%
3,509
57.9%
1.2%
Biliary Atresia
314
93.4%
2.0%
314
91.0%
2.3%
914
84.3%
1.9%
1,671
78.8%
1.7%
Metabolic Diseases
304
93.0%
1.5%
304
90.1%
1.8%
972
80.3%
1.5%
1,666
71.6%
1.6%
Malignant Neoplasms
1,865
95.8%
0.5%
1,865
89.2%
0.7%
4,127
67.5%
1.0%
4,821
53.1%
1.9%
Other
322
90.6%
1.7%
322
85.7%
2.1%
1,419
70.9%
1.4%
2,176
61.6%
1.6%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Patient survival follows patients from first transplant of this type until death.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on liver transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.